Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have developed a new portable plasma device ...
Zacks Investment Research on MSN
ADMA vs Takeda: Which plasma therapy stock is the better buy today?
ADMA Biologics ADMA and Takeda TAK are prominent players in the plasma-derived immunoglobulin space. ADMA focuses on plasma-based biologics to treat immune deficiencies and help prevent certain ...
TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI) and US Medical Innovations, LLC (USMI) announced today that the full ...
Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...
ADMA Biologics ADMA and Grifols GRFS are leading producers of plasma-derived therapies, specializing in immunoglobulin treatments for immunodeficiencies and other conditions. ADMA Biologics markets ...
Surfx Technologies offers engineers and manufacturers products to enable a deeper understanding of medical device polymer treatment. It provides reliable automated plasma machines for in-line surface ...
The first thing John* smelled was his wife’s hair. Then coffee, sautéed scallops and a pile of compost. For someone who hadn’t been able to smell anything for 45 years, it seemed like a miracle. As a ...
Researchers at the Nankai University in China have fabricated a perovskite solar cell using a 2D/3D perovskite heterointerface that improves device stability and performance. The research team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results